首页 > 最新文献

Journal of Cardiovascular Magnetic Resonance最新文献

英文 中文
Rest and exercise-stress estimated pulmonary capillary wedge pressure using real-time free-breathing cardiovascular magnetic resonance imaging. 利用实时自由呼吸心血管磁共振成像技术估算静息和运动压力下的肺毛细血管楔压。
IF 6.4 1区 医学 Q1 Medicine Pub Date : 2024-06-01 Epub Date: 2024-02-29 DOI: 10.1016/j.jocmr.2024.101032
Sören J Backhaus, Alexander Schulz, Torben Lange, Ruben Evertz, Johannes T Kowallick, Gerd Hasenfuß, Andreas Schuster

Background: Identification of increased pulmonary capillary wedge pressure (PCWP) by right heart catheterization (RHC) is the reference standard for the diagnosis of heart failure with preserved ejection fraction (HFpEF). Recently, cardiovascular magnetic resonance (CMR) imaging estimation of PCWP at rest was introduced as a non-invasive alternative. Since many patients are only identified during physiological exercise-stress, we hypothesized that novel exercise-stress CMR-derived PCWP emerges superior compared to its assessment at rest.

Methods: The HFpEF-Stress Trial prospectively recruited 75 patients with exertional dyspnea and diastolic dysfunction who then underwent rest and exercise-stress RHC and CMR. HFpEF was defined according to PCWP (overt HFpEF ≥15 mmHg at rest, masked HFpEF ≥25 mmHg during exercise-stress). CMR-derived PCWP was calculated based on previously published formula using left ventricular mass and either biplane left atrial volume (LAV) or monoplane left atrial area (LAA).

Results: LAV (rest/stress: r = 0.50/r = 0.55, p < 0.001) and LAA PCWP (rest/stress: r = 0.50/r = 0.48, p < 0.001) correlated significantly with RHC-derived PCWP while numerically overestimating PCWP at rest and underestimating PCWP during exercise-stress. LAV and LAA PCWP showed good diagnostic accuracy to detect HFpEF (area under the receiver operating characteristic curve (AUC) LAV rest 0.73, stress 0.81; LAA rest 0.72, stress 0.77) with incremental diagnostic value for the detection of masked HFpEF using exercise-stress (AUC LAV rest 0.54 vs stress 0.67, p = 0.019, LAA rest 0.52 vs stress 0.66, p = 0.012). LAV but not LAA PCWP during exercise-stress was a predictor for 24 months hospitalization independent of a medical history for atrial fibrillation (hazard ratio (HR) 1.26, 95% confidence interval 1.02-1.55, p = 0.032).

Conclusion: Non-invasive PCWP correlates well with the invasive reference at rest and during exercise stress. There is overall good diagnostic accuracy for HFpEF assessment using CMR-derived estimated PCWP despite deviations in absolute agreement. Non-invasive exercise derived PCWP may particularly facilitate detection of masked HFpEF in the future.

背景:右心导管检查(RHC)发现肺毛细血管楔压(PCWP)升高是诊断射血分数保留型心力衰竭(HFpEF)的参考标准。最近,心血管磁共振(CMR)成像估测静息状态下的 PCWP 成为一种无创替代方法。由于许多患者只有在生理运动应激时才会被发现,我们假设新的运动应激CMR得出的PCWP比静息时的评估结果更优:方法:HFpEF-应激试验前瞻性地招募了 75 名患有劳累性呼吸困难和舒张功能障碍的患者,这些患者随后接受了静息和运动应激 RHC 和 CMR 检查。根据 PCWP 对 HFpEF 进行定义(静息时明显 HFpEF ≥15mmHg,运动应激时掩蔽 HFpEF ≥25mmHg)。CMR得出的PCWP是根据之前发表的公式,使用左心室质量(LVM)和双平面左心房容积(LAV)或单平面左心房面积(LAA)计算得出的:结果:LAV(静息/压力:r=0.50/r=0.55,p结论:无创 PCWP 与有创参考值在静息和运动负荷时的相关性良好。尽管绝对值存在偏差,但使用 CMR 推算的 PCWP 评估 HFpEF 总体诊断准确性良好。未来,无创运动得出的 PCWP 可能尤其有助于检测被掩盖的 HFpEF。
{"title":"Rest and exercise-stress estimated pulmonary capillary wedge pressure using real-time free-breathing cardiovascular magnetic resonance imaging.","authors":"Sören J Backhaus, Alexander Schulz, Torben Lange, Ruben Evertz, Johannes T Kowallick, Gerd Hasenfuß, Andreas Schuster","doi":"10.1016/j.jocmr.2024.101032","DOIUrl":"10.1016/j.jocmr.2024.101032","url":null,"abstract":"<p><strong>Background: </strong>Identification of increased pulmonary capillary wedge pressure (PCWP) by right heart catheterization (RHC) is the reference standard for the diagnosis of heart failure with preserved ejection fraction (HFpEF). Recently, cardiovascular magnetic resonance (CMR) imaging estimation of PCWP at rest was introduced as a non-invasive alternative. Since many patients are only identified during physiological exercise-stress, we hypothesized that novel exercise-stress CMR-derived PCWP emerges superior compared to its assessment at rest.</p><p><strong>Methods: </strong>The HFpEF-Stress Trial prospectively recruited 75 patients with exertional dyspnea and diastolic dysfunction who then underwent rest and exercise-stress RHC and CMR. HFpEF was defined according to PCWP (overt HFpEF ≥15 mmHg at rest, masked HFpEF ≥25 mmHg during exercise-stress). CMR-derived PCWP was calculated based on previously published formula using left ventricular mass and either biplane left atrial volume (LAV) or monoplane left atrial area (LAA).</p><p><strong>Results: </strong>LAV (rest/stress: r = 0.50/r = 0.55, p < 0.001) and LAA PCWP (rest/stress: r = 0.50/r = 0.48, p < 0.001) correlated significantly with RHC-derived PCWP while numerically overestimating PCWP at rest and underestimating PCWP during exercise-stress. LAV and LAA PCWP showed good diagnostic accuracy to detect HFpEF (area under the receiver operating characteristic curve (AUC) LAV rest 0.73, stress 0.81; LAA rest 0.72, stress 0.77) with incremental diagnostic value for the detection of masked HFpEF using exercise-stress (AUC LAV rest 0.54 vs stress 0.67, p = 0.019, LAA rest 0.52 vs stress 0.66, p = 0.012). LAV but not LAA PCWP during exercise-stress was a predictor for 24 months hospitalization independent of a medical history for atrial fibrillation (hazard ratio (HR) 1.26, 95% confidence interval 1.02-1.55, p = 0.032).</p><p><strong>Conclusion: </strong>Non-invasive PCWP correlates well with the invasive reference at rest and during exercise stress. There is overall good diagnostic accuracy for HFpEF assessment using CMR-derived estimated PCWP despite deviations in absolute agreement. Non-invasive exercise derived PCWP may particularly facilitate detection of masked HFpEF in the future.</p>","PeriodicalId":15221,"journal":{"name":"Journal of Cardiovascular Magnetic Resonance","volume":null,"pages":null},"PeriodicalIF":6.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10950869/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140021864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiovascular magnetic resonance imaging and clinical follow-up in patients with clinically suspected myocarditis after COVID-19 vaccination. 接种 COVID-19 疫苗后临床疑似心肌炎患者的心血管磁共振成像和临床随访。
IF 6.4 1区 医学 Q1 Medicine Pub Date : 2024-06-01 Epub Date: 2024-03-11 DOI: 10.1016/j.jocmr.2024.101036
Norain Talib, Matteo Fronza, Constantin Arndt Marschner, Paaladinesh Thavendiranathan, Gauri Rani Karur, Kate Hanneman

Background: The purpose of this study was to evaluate cardiovascular magnetic resonance (CMR) findings and their relationship to longer-term clinical outcomes in patients with suspected myocarditis following coronavirus disease 2019 (COVID-19) vaccination.

Methods: Consecutive adult patients who underwent clinically indicated CMR for evaluation of suspected myocarditis following messenger ribonucleic acid (mRNA)-based COVID-19 vaccination at a single center between 2021 and 2022 were retrospectively evaluated. Patients were classified based on the revised Lake Louise criteria for T1-based abnormalities (late gadolinium enhancement [LGE] or high T1 values) and T2-based abnormalities (regional T2-hyperintensity or high T2 values).

Results: Eighty-nine patients were included (64% [57/89] male, mean age 34 ± 13 years, 38% [32/89] mRNA-1273, and 62% [52/89] BNT162b2). On baseline CMR, 42 (47%) had at least one abnormality; 25 (28%) met both T1- and T2-criteria; 17 (19%) met T1-criteria but not T2-criteria; and 47 (53%) did not meet either. The interval between vaccination and CMR was shorter in those who met T1- and T2-criteria (28 days, IQR 8-69) compared to those who met T1-criteria only (110 days, IQR 66-255, p < 0.001) and those who did not meet either (120 days, interquartile range (IQR) 80-252, p < 0.001). In the subset of 21 patients who met both T1- and T2-criteria at baseline and had follow-up CMR, myocardial edema had resolved and left ventricular ejection fraction had normalized in all at median imaging follow-up of 214 days (IQR 132-304). However, minimal LGE persisted in 10 (48%). At median clinical follow-up of 232 days (IQR 156-405, n = 60), there were no adverse cardiac events. However, mild cardiac symptoms persisted in 7 (12%).

Conclusion: In a cohort of patients who underwent clinically indicated CMR for suspected myocarditis following COVID-19 vaccination, 47% had at least one abnormality at baseline CMR. Detection of myocardial edema was associated with the timing of CMR after vaccination. There were no adverse cardiac events. However, minimal LGE persisted in 48% at follow-up.

背景:本研究旨在评估接种 COVID-19 疫苗后疑似心肌炎患者的心血管磁共振(CMR)结果及其与长期临床结果的关系:本研究旨在评估COVID-19疫苗接种后疑似心肌炎患者的心血管磁共振(CMR)结果及其与长期临床结果的关系:回顾性评估了 2021-2022 年间在一个中心接种基于 mRNA 的 COVID-19 疫苗后接受有临床指征的 CMR 评估疑似心肌炎的连续成年患者。根据修订后的路易斯湖标准对患者进行分类,包括基于 T1 的异常(晚期钆增强或高 T1 值)和基于 T2 的异常(区域性 T2- 高强度或高 T2 值):共纳入 89 例患者(男性占 64%,平均年龄为 34±13 岁,mRNA-1273 占 38%,BNT162b2 占 62%)。在基线 CMR 中,42 人(47%)至少有一项异常;25 人(28%)同时符合 T1 和 T2 标准;17 人(19%)符合 T1 标准,但不符合 T2 标准;47 人(53%)两项均不符合。与仅符合 T1 标准的患者(110 天,IQR 66-255,p 结论)相比,符合 T1 和 T2 标准的患者从接种疫苗到进行 CMR 的时间间隔较短(28 天,IQR 8-69):在一组因接种 COVID-19 疫苗后疑似心肌炎而接受临床指征 CMR 的患者中,47% 的患者在基线 CMR 时至少有一项异常。心肌水肿的发现与接种后进行 CMR 的时间有关。没有发生不良心脏事件。然而,48%的患者在随访时仍存在轻微的LGE。
{"title":"Cardiovascular magnetic resonance imaging and clinical follow-up in patients with clinically suspected myocarditis after COVID-19 vaccination.","authors":"Norain Talib, Matteo Fronza, Constantin Arndt Marschner, Paaladinesh Thavendiranathan, Gauri Rani Karur, Kate Hanneman","doi":"10.1016/j.jocmr.2024.101036","DOIUrl":"10.1016/j.jocmr.2024.101036","url":null,"abstract":"<p><strong>Background: </strong>The purpose of this study was to evaluate cardiovascular magnetic resonance (CMR) findings and their relationship to longer-term clinical outcomes in patients with suspected myocarditis following coronavirus disease 2019 (COVID-19) vaccination.</p><p><strong>Methods: </strong>Consecutive adult patients who underwent clinically indicated CMR for evaluation of suspected myocarditis following messenger ribonucleic acid (mRNA)-based COVID-19 vaccination at a single center between 2021 and 2022 were retrospectively evaluated. Patients were classified based on the revised Lake Louise criteria for T1-based abnormalities (late gadolinium enhancement [LGE] or high T1 values) and T2-based abnormalities (regional T2-hyperintensity or high T2 values).</p><p><strong>Results: </strong>Eighty-nine patients were included (64% [57/89] male, mean age 34 ± 13 years, 38% [32/89] mRNA-1273, and 62% [52/89] BNT162b2). On baseline CMR, 42 (47%) had at least one abnormality; 25 (28%) met both T1- and T2-criteria; 17 (19%) met T1-criteria but not T2-criteria; and 47 (53%) did not meet either. The interval between vaccination and CMR was shorter in those who met T1- and T2-criteria (28 days, IQR 8-69) compared to those who met T1-criteria only (110 days, IQR 66-255, p < 0.001) and those who did not meet either (120 days, interquartile range (IQR) 80-252, p < 0.001). In the subset of 21 patients who met both T1- and T2-criteria at baseline and had follow-up CMR, myocardial edema had resolved and left ventricular ejection fraction had normalized in all at median imaging follow-up of 214 days (IQR 132-304). However, minimal LGE persisted in 10 (48%). At median clinical follow-up of 232 days (IQR 156-405, n = 60), there were no adverse cardiac events. However, mild cardiac symptoms persisted in 7 (12%).</p><p><strong>Conclusion: </strong>In a cohort of patients who underwent clinically indicated CMR for suspected myocarditis following COVID-19 vaccination, 47% had at least one abnormality at baseline CMR. Detection of myocardial edema was associated with the timing of CMR after vaccination. There were no adverse cardiac events. However, minimal LGE persisted in 48% at follow-up.</p>","PeriodicalId":15221,"journal":{"name":"Journal of Cardiovascular Magnetic Resonance","volume":null,"pages":null},"PeriodicalIF":6.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11004989/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140119564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fractal analysis: another tool for the toolbox for dilated cardiomyopathy prognostication? 分形分析:DCM 预后工具箱中的又一工具?
IF 6.4 1区 医学 Q1 Medicine Pub Date : 2024-06-01 Epub Date: 2024-02-02 DOI: 10.1016/j.jocmr.2024.101004
Fiona Chan, Gabriella Captur
{"title":"Fractal analysis: another tool for the toolbox for dilated cardiomyopathy prognostication?","authors":"Fiona Chan, Gabriella Captur","doi":"10.1016/j.jocmr.2024.101004","DOIUrl":"10.1016/j.jocmr.2024.101004","url":null,"abstract":"","PeriodicalId":15221,"journal":{"name":"Journal of Cardiovascular Magnetic Resonance","volume":null,"pages":null},"PeriodicalIF":6.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10944259/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139681084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Highly efficient free-breathing 3D whole-heart imaging in 3-min: single center study in adults with congenital heart disease. 3 分钟高效自由呼吸三维全心成像:对患有先天性心脏病的成人进行的单中心研究。
IF 4.2 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-06-01 Epub Date: 2023-12-22 DOI: 10.1016/j.jocmr.2023.100008
Anastasia Fotaki, Kuberan Pushparajah, Christopher Rush, Camila Munoz, Carlos Velasco, Radhouene Neji, Karl P Kunze, René M Botnar, Claudia Prieto

Background: Three dimensional, whole-heart (3DWH) MRI is an established non-invasive imaging modality in patients with congenital heart disease (CHD) for the diagnosis of cardiovascular morphology and for clinical decision making. Current techniques utilise diaphragmatic navigation (dNAV) for respiratory motion correction and gating and are frequently limited by long acquisition times. This study proposes and evaluates the diagnostic performance of a respiratory gating-free framework, which considers respiratory image-based navigation (iNAV), and highly accelerated variable density Cartesian sampling in concert with non-rigid motion correction and low-rank patch-based denoising (iNAV-3DWH-PROST). The method is compared to the clinical dNAV-3DWH sequence in adult patients with CHD.

Methods: In this prospective single center study, adult patients with CHD who underwent the clinical dNAV-3DWH MRI were also scanned with the iNAV-3DWH-PROST. Diagnostic confidence (4-point Likert scale) and diagnostic accuracy for common cardiovascular lesions was assessed by three readers. Scan times and diagnostic confidence were compared using the Wilcoxon-signed rank test. Co-axial vascular dimensions at three anatomic landmarks were measured, and agreement between the research and the corresponding clinical sequence was assessed with Bland-Altman analysis.

Results: The study included 60 participants (mean age ± [SD]: 33 ± 14 years; 36 men). The mean acquisition time of iNAV-3DWH-PROST was significantly lower compared with the conventional clinical sequence (3.1 ± 0.9 min vs 13.9 ± 3.9 min, p < 0.0001). Diagnostic confidence was higher for the iNAV-3DWH-PROST sequence compared with the clinical sequence (3.9 ± 0.2 vs 3.4 ± 0.8, p < 0.001), however there was no significant difference in diagnostic accuracy. Narrow limits of agreement and mean bias less than 0.08 cm were found between the research and the clinical vascular measurements.

Conclusions: The iNAV-3DWH-PROST framework provides efficient, high quality and robust 3D whole-heart imaging in significantly shorter scan time compared to the standard clinical sequence.

背景:三维全心(3DWH)磁共振成像是一种成熟的无创成像模式,可用于先天性心脏病(CHD)患者的心血管形态诊断和临床决策。目前的技术利用膈肌导航(dNAV)进行呼吸运动校正和选通,但经常受到采集时间过长的限制。本研究提出并评估了无呼吸门控框架的诊断性能,该框架考虑了基于呼吸图像的导航(inaV)、高度加速的可变密度笛卡尔采样以及非刚性运动校正和基于低阶补丁的去噪(inaV-3DWH-PROST)。该方法与临床 dNAV-3DWH 序列在成人心脏病患者中的应用进行了比较:在这项前瞻性单中心研究中,接受临床 dNAV-3DWH MRI 扫描的成人冠心病患者也接受了 iNAV-3DWH-PROST 扫描。由三名阅读者对常见心血管病变的诊断信心(4 点 Likert 量表)和诊断准确性进行评估。扫描时间和诊断信心采用 Wilcoxon-signed 秩检验进行比较。测量了三个解剖标记处的同轴血管尺寸,并通过布兰-阿尔特曼分析评估了研究与相应临床序列之间的一致性:该研究包括 60 名参与者(平均年龄 ± [标码]:33 ± 14 岁;36 名男性)。与传统临床序列相比,inaV-3DWH-PROST 的平均采集时间明显缩短(3.1±0.9 分钟 vs 13.9±3.9 分钟,p 结论:inaV-3DWH-PROST 的平均采集时间明显缩短(3.1±0.9 分钟 vs 13.9±3.9 分钟,p 结论):与标准临床序列相比,inaV-3DWH-PROST 框架能在更短的扫描时间内提供高效、高质量和稳健的三维全心成像。
{"title":"Highly efficient free-breathing 3D whole-heart imaging in 3-min: single center study in adults with congenital heart disease.","authors":"Anastasia Fotaki, Kuberan Pushparajah, Christopher Rush, Camila Munoz, Carlos Velasco, Radhouene Neji, Karl P Kunze, René M Botnar, Claudia Prieto","doi":"10.1016/j.jocmr.2023.100008","DOIUrl":"10.1016/j.jocmr.2023.100008","url":null,"abstract":"<p><strong>Background: </strong>Three dimensional, whole-heart (3DWH) MRI is an established non-invasive imaging modality in patients with congenital heart disease (CHD) for the diagnosis of cardiovascular morphology and for clinical decision making. Current techniques utilise diaphragmatic navigation (dNAV) for respiratory motion correction and gating and are frequently limited by long acquisition times. This study proposes and evaluates the diagnostic performance of a respiratory gating-free framework, which considers respiratory image-based navigation (iNAV), and highly accelerated variable density Cartesian sampling in concert with non-rigid motion correction and low-rank patch-based denoising (iNAV-3DWH-PROST). The method is compared to the clinical dNAV-3DWH sequence in adult patients with CHD.</p><p><strong>Methods: </strong>In this prospective single center study, adult patients with CHD who underwent the clinical dNAV-3DWH MRI were also scanned with the iNAV-3DWH-PROST. Diagnostic confidence (4-point Likert scale) and diagnostic accuracy for common cardiovascular lesions was assessed by three readers. Scan times and diagnostic confidence were compared using the Wilcoxon-signed rank test. Co-axial vascular dimensions at three anatomic landmarks were measured, and agreement between the research and the corresponding clinical sequence was assessed with Bland-Altman analysis.</p><p><strong>Results: </strong>The study included 60 participants (mean age ± [SD]: 33 ± 14 years; 36 men). The mean acquisition time of iNAV-3DWH-PROST was significantly lower compared with the conventional clinical sequence (3.1 ± 0.9 min vs 13.9 ± 3.9 min, p < 0.0001). Diagnostic confidence was higher for the iNAV-3DWH-PROST sequence compared with the clinical sequence (3.9 ± 0.2 vs 3.4 ± 0.8, p < 0.001), however there was no significant difference in diagnostic accuracy. Narrow limits of agreement and mean bias less than 0.08 cm were found between the research and the clinical vascular measurements.</p><p><strong>Conclusions: </strong>The iNAV-3DWH-PROST framework provides efficient, high quality and robust 3D whole-heart imaging in significantly shorter scan time compared to the standard clinical sequence.</p>","PeriodicalId":15221,"journal":{"name":"Journal of Cardiovascular Magnetic Resonance","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11211218/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139402988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A new era for JCMR. JCMR 的新纪元。
IF 4.2 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-06-01 Epub Date: 2023-12-26 DOI: 10.1016/j.jocmr.2023.100009
Tim Leiner
{"title":"A new era for JCMR.","authors":"Tim Leiner","doi":"10.1016/j.jocmr.2023.100009","DOIUrl":"10.1016/j.jocmr.2023.100009","url":null,"abstract":"","PeriodicalId":15221,"journal":{"name":"Journal of Cardiovascular Magnetic Resonance","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11211217/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141300763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mitral valve orifice area predicts outcome after biventricular repair in patients with hypoplastic left ventricles. 二尖瓣口面积可预测左心室发育不全患者双心室修复术后的效果
IF 6.4 1区 医学 Q1 Medicine Pub Date : 2024-06-01 Epub Date: 2024-02-23 DOI: 10.1016/j.jocmr.2024.101029
David Liddle, Addison Gearhart, Lynn A Sleeper, Minmin Lu, Eric Feins, David N Schidlow, Sunil Ghelani, Andrew J Powell, Sitaram Emani, Rebecca S Beroukhim

Background: Identification of risk factors for biventricular (BiV) repair in children with hypoplastic left ventricles (HLV) has been challenging. We sought to identify preoperative cardiovascular magnetic resonance (CMR) predictors of outcome in patients with HLVs who underwent BiV repair, with a focus on the mitral valve (MV).

Methods: Single-center retrospective analysis of preoperative CMRs on patients with HLV (≤50 mL/m2) and no endocardial fibroelastosis who underwent BiV repair from 2005-2022. CMR measurements included MV orifice area in diastole. The primary composite outcome included time to death, transplant, BiV takedown, heart failure admission, left atrial decompression, or unexpected reoperation; and the secondary outcome included more than or equal to moderate mitral stenosis and/or regurgitation.

Results: Median follow-up was 0.7 (interquartile range 0.1, 2.2) years. Of 122 patients [59 atrioventricular canal (AVC) and 63 non-AVC] age 3 ± 2.8 years at the time of BiV repair, freedom from the primary outcome at 2 years was 53% for AVC and 69% for non-AVC (log rank p = 0.12), and freedom from the secondary outcome at 2 years was 49% for AVC and 79% for non-AVC (log rank p < 0.01). Independent predictors of primary outcome for AVC patients included MV orifice area z-score <-2 and transitional AVC; for non-AVC patients, predictors included MV orifice area z-score <-2, abnormal MV anatomy, and conal-septal ventricular septal defect. Independent predictors of secondary outcome for AVC patients included older age at surgery, transitional AVC, and transposition of the great arteries.

Conclusion: In children with HLV, low MV orifice area and pre-existing MV pathology are risk factors for adverse outcome after BiV repair.

背景:鉴定左心室发育不全(HLV)儿童双心室(BiV)修复术的风险因素一直是一项挑战。我们试图确定接受双室修复术的 HLV 患者术前心血管磁共振(CMR)预测结果的因素,重点是二尖瓣(MV):单中心回顾性分析 2005-2022 年间接受 BiV 修复术的 HLV(≤50ml/m2)和无心内膜纤维增生症患者的术前 CMR。CMR 测量包括舒张期中流孔面积。主要复合结果包括死亡、移植、BiV撕裂、心衰入院、左房减压或意外再次手术的时间;次要结果包括≥中度二尖瓣狭窄和/或反流:中位随访时间为 0.7(IQR 0.1,2.2)年。122名患者中(48%为房室管(AVC),52%为非AVC),BiV修复时年龄为(3 ± 2.8)岁,2年后AVC患者无主要结果的比例为53%,非AVC患者为69%(对数秩p=0.12),2年后AVC患者无次要结果的比例为49%,非AVC患者为79%(对数秩p):在HLV患儿中,低中流道孔面积和先前存在的中流道病变是导致BiV修复术后不良预后的风险因素。
{"title":"Mitral valve orifice area predicts outcome after biventricular repair in patients with hypoplastic left ventricles.","authors":"David Liddle, Addison Gearhart, Lynn A Sleeper, Minmin Lu, Eric Feins, David N Schidlow, Sunil Ghelani, Andrew J Powell, Sitaram Emani, Rebecca S Beroukhim","doi":"10.1016/j.jocmr.2024.101029","DOIUrl":"10.1016/j.jocmr.2024.101029","url":null,"abstract":"<p><strong>Background: </strong>Identification of risk factors for biventricular (BiV) repair in children with hypoplastic left ventricles (HLV) has been challenging. We sought to identify preoperative cardiovascular magnetic resonance (CMR) predictors of outcome in patients with HLVs who underwent BiV repair, with a focus on the mitral valve (MV).</p><p><strong>Methods: </strong>Single-center retrospective analysis of preoperative CMRs on patients with HLV (≤50 mL/m<sup>2</sup>) and no endocardial fibroelastosis who underwent BiV repair from 2005-2022. CMR measurements included MV orifice area in diastole. The primary composite outcome included time to death, transplant, BiV takedown, heart failure admission, left atrial decompression, or unexpected reoperation; and the secondary outcome included more than or equal to moderate mitral stenosis and/or regurgitation.</p><p><strong>Results: </strong>Median follow-up was 0.7 (interquartile range 0.1, 2.2) years. Of 122 patients [59 atrioventricular canal (AVC) and 63 non-AVC] age 3 ± 2.8 years at the time of BiV repair, freedom from the primary outcome at 2 years was 53% for AVC and 69% for non-AVC (log rank p = 0.12), and freedom from the secondary outcome at 2 years was 49% for AVC and 79% for non-AVC (log rank p < 0.01). Independent predictors of primary outcome for AVC patients included MV orifice area z-score <-2 and transitional AVC; for non-AVC patients, predictors included MV orifice area z-score <-2, abnormal MV anatomy, and conal-septal ventricular septal defect. Independent predictors of secondary outcome for AVC patients included older age at surgery, transitional AVC, and transposition of the great arteries.</p><p><strong>Conclusion: </strong>In children with HLV, low MV orifice area and pre-existing MV pathology are risk factors for adverse outcome after BiV repair.</p>","PeriodicalId":15221,"journal":{"name":"Journal of Cardiovascular Magnetic Resonance","volume":null,"pages":null},"PeriodicalIF":6.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10965470/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139972025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diastolic function assessment with four-dimensional flow cardiovascular magnetic resonance using automatic deep learning E/A ratio analysis. 利用自动深度学习 EA 比率分析通过四维血流 CMR 评估舒张功能。
IF 6.4 1区 医学 Q1 Medicine Pub Date : 2024-06-01 Epub Date: 2024-03-30 DOI: 10.1016/j.jocmr.2024.101042
Federica Viola, Mariana Bustamante, Ann Bolger, Jan Engvall, Tino Ebbers

Background: Diastolic left ventricular (LV) dysfunction is a powerful contributor to the symptoms and prognosis of patients with heart failure. In patients with depressed LV systolic function, the E/A ratio, the ratio between the peak early (E) and the peak late (A) transmitral flow velocity, is the first step to defining the grade of diastolic dysfunction. Doppler echocardiography (echo) is the preferred imaging technique for diastolic function assessment, while cardiovascular magnetic resonance (CMR) is less established as a method. Previous four-dimensional (4D) Flow-based studies have looked at the E/A ratio proximal to the mitral valve, requiring manual interaction. In this study, we compare an automated, deep learning-based and two semi-automated approaches for 4D Flow CMR-based E/A ratio assessment to conventional, gold-standard echo-based methods.

Methods: Ninety-seven subjects with chronic ischemic heart disease underwent a cardiac echo followed by CMR investigation. 4D Flow-based E/A ratio values were computed using three different approaches; two semi-automated, assessing the E/A ratio by measuring the inflow velocity (MVvel) and the inflow volume (MVflow) at the mitral valve plane, and one fully automated, creating a full LV segmentation using a deep learning-based method with which the E/A ratio could be assessed without constraint to the mitral plane (LVvel).

Results: MVvel, MVflow, and LVvel E/A ratios were strongly associated with echocardiographically derived E/A ratio (R2 = 0.60, 0.58, 0.72). LVvel peak E and A showed moderate association to Echo peak E and A, while MVvel values were weakly associated. MVvel and MVflow EA ratios were very strongly associated with LVvel (R2 = 0.84, 0.86). MVvel peak E was moderately associated with LVvel, while peak A showed a strong association (R2 = 0.26, 0.57).

Conclusion: Peak E, peak A, and E/A ratio are integral to the assessment of diastolic dysfunction and may expand the utility of CMR studies in patients with cardiovascular disease. While underestimation of absolute peak E and A velocities was noted, the E/A ratio measured with all three 4D Flow methods was strongly associated with the gold standard Doppler echocardiography. The automatic, deep learning-based method performed best, with the most favorable runtime of ∼40 seconds. As both semi-automatic methods associated very strongly to LVvel, they could be employed as an alternative for estimation of E/A ratio.

背景:左心室舒张功能障碍对心力衰竭患者的症状和预后有很大影响。对于左室收缩功能减退的患者,EA 比值是确定舒张功能障碍等级的第一步。多普勒超声心动图是舒张功能评估的首选成像技术,而 CMR 作为一种方法还不太成熟。之前基于四维血流的研究主要观察二尖瓣近端的 EA 比值,需要人工操作。在本研究中,我们比较了基于 4D Flow CMR 的自动深度学习 EA 比值评估方法和两种半自动方法,以及基于回波的传统金标准方法:97名慢性缺血性心脏病患者接受了心脏回波检查和核磁共振成像检查。使用三种不同的方法计算基于 4D 流量的 EA 比值;两种是半自动方法,通过测量二尖瓣平面的血流速度(MVvel)和血流容量(MVflow)来评估 EA 比值;一种是全自动方法,使用基于深度学习的方法创建完整的 LV 分割,在此范围内评估 EA 比值而不受二尖瓣平面(LVvel)的限制:结果:MVvel、MVflow 和 LVvel EA 比值与 Echo EA 比值密切相关(R2= 0.60、0.58、0.72)。LVvel 峰值 E 和 A 与 Echo 峰值 E 和 A 呈中度相关,而 MVvel 值则呈弱相关。MVvel 和 MVflow EA 比值与 LVvel 的相关性非常强(R2= 0.84、0.86)。MVvel E 峰与 LVvel 的相关性一般,而 A 峰与 LVvel 的相关性较强(R2= 0.26,0.57):讨论与结论:E 峰、A 峰和 EA 比值是评估舒张功能障碍不可或缺的指标,可扩大心血管疾病患者 CMR 研究的实用性。虽然E峰值和A峰值速度的绝对值被低估,但所有三种4D Flow方法测得的EA比值与金标准多普勒超声心动图密切相关。基于深度学习的自动方法表现最佳,运行时间约为 40 秒。由于这两种半自动方法与 LVvel 的相关性非常强,因此可作为估算 EA 比值的替代方法。
{"title":"Diastolic function assessment with four-dimensional flow cardiovascular magnetic resonance using automatic deep learning E/A ratio analysis.","authors":"Federica Viola, Mariana Bustamante, Ann Bolger, Jan Engvall, Tino Ebbers","doi":"10.1016/j.jocmr.2024.101042","DOIUrl":"10.1016/j.jocmr.2024.101042","url":null,"abstract":"<p><strong>Background: </strong>Diastolic left ventricular (LV) dysfunction is a powerful contributor to the symptoms and prognosis of patients with heart failure. In patients with depressed LV systolic function, the E/A ratio, the ratio between the peak early (E) and the peak late (A) transmitral flow velocity, is the first step to defining the grade of diastolic dysfunction. Doppler echocardiography (echo) is the preferred imaging technique for diastolic function assessment, while cardiovascular magnetic resonance (CMR) is less established as a method. Previous four-dimensional (4D) Flow-based studies have looked at the E/A ratio proximal to the mitral valve, requiring manual interaction. In this study, we compare an automated, deep learning-based and two semi-automated approaches for 4D Flow CMR-based E/A ratio assessment to conventional, gold-standard echo-based methods.</p><p><strong>Methods: </strong>Ninety-seven subjects with chronic ischemic heart disease underwent a cardiac echo followed by CMR investigation. 4D Flow-based E/A ratio values were computed using three different approaches; two semi-automated, assessing the E/A ratio by measuring the inflow velocity (MVvel) and the inflow volume (MVflow) at the mitral valve plane, and one fully automated, creating a full LV segmentation using a deep learning-based method with which the E/A ratio could be assessed without constraint to the mitral plane (LVvel).</p><p><strong>Results: </strong>MVvel, MVflow, and LVvel E/A ratios were strongly associated with echocardiographically derived E/A ratio (R<sup>2</sup> = 0.60, 0.58, 0.72). LVvel peak E and A showed moderate association to Echo peak E and A, while MVvel values were weakly associated. MVvel and MVflow EA ratios were very strongly associated with LVvel (R<sup>2</sup> = 0.84, 0.86). MVvel peak E was moderately associated with LVvel, while peak A showed a strong association (R<sup>2</sup> = 0.26, 0.57).</p><p><strong>Conclusion: </strong>Peak E, peak A, and E/A ratio are integral to the assessment of diastolic dysfunction and may expand the utility of CMR studies in patients with cardiovascular disease. While underestimation of absolute peak E and A velocities was noted, the E/A ratio measured with all three 4D Flow methods was strongly associated with the gold standard Doppler echocardiography. The automatic, deep learning-based method performed best, with the most favorable runtime of ∼40 seconds. As both semi-automatic methods associated very strongly to LVvel, they could be employed as an alternative for estimation of E/A ratio.</p>","PeriodicalId":15221,"journal":{"name":"Journal of Cardiovascular Magnetic Resonance","volume":null,"pages":null},"PeriodicalIF":6.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11058894/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140331729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of dysglycaemia with persistent infarct core iron in patients with acute ST-segment elevation myocardial infarction. 急性 ST 段抬高型心肌梗死患者血糖异常与梗死核心铁持续存在的关系
IF 4.2 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-06-01 Epub Date: 2024-01-17 DOI: 10.1016/j.jocmr.2024.100996
Ivan Lechner, Martin Reindl, Fritz Oberhollenzer, Christina Tiller, Magdalena Holzknecht, Priscilla Fink, Thomas Kremser, Paolo Bonatti, Felix Troger, Benjamin Henninger, Agnes Mayr, Axel Bauer, Bernhard Metzler, Sebastian J Reinstadler

Background: Dysglycaemia increases the risk of myocardial infarction and subsequent recurrent cardiovascular events. However, the role of dysglycaemia in ischemia/reperfusion injury with development of irreversible myocardial tissue alterations remains poorly understood. In this study we aimed to investigate the association of ongoing dysglycaemia with persistence of infarct core iron and their longitudinal changes over time in patients undergoing primary percutaneous coronary intervention (PCI) for acute ST-segment elevation myocardial infarction (STEMI).

Methods: We analyzed 348 STEMI patients treated with primary PCI between 2016 and 2021 that were included in the prospective MARINA-STEMI study (NCT04113356). Peripheral venous blood samples for glucose and glycated hemoglobin (HbA1c) measurements were drawn on admission and 4 months after STEMI. Cardiac magnetic resonance (CMR) imaging including T2 * mapping for infarct core iron assessment was performed at both time points. Associations of dysglycaemia with persistent infarct core iron and iron resolution at 4 months were calculated using multivariable regression analysis.

Results: Intramyocardial hemorrhage was observed in 147 (42%) patients at baseline. Of these, 89 (61%) had persistent infarct core iron 4 months after infarction with increasing rates across HbA1c levels (<5.7%: 33%, ≥5.7: 79%). Persistent infarct core iron was independently associated with ongoing dysglycaemia defined by HbA1c at 4 months (OR: 7.87 [95% CI: 2.60-23.78]; p < 0.001), after adjustment for patient characteristics and CMR parameters. The independent association was present even after exclusion of patients with diabetes (pre- and newly diagnosed, n = 16).

Conclusions: In STEMI patients treated with primary PCI, ongoing dysglycaemia defined by HbA1c is independently associated with persistent infarct core iron and a lower likelihood of iron resolution. These findings suggest a potential association between ongoing dysglycaemia and persistent infarct core iron, which warrants further investigation for therapeutic implications.

背景:血糖异常会增加心肌梗死和随后的心血管事件复发的风险。然而,人们对血糖异常在心肌缺血/再灌注损伤和心肌组织不可逆改变中的作用仍知之甚少。在这项研究中,我们旨在调查因急性 ST 段抬高型心肌梗死(STEMI)而接受初级经皮冠状动脉介入治疗(PCI)的患者中,持续的血糖异常与梗死核心铁持续存在的关系及其随时间的纵向变化:我们分析了2016年至2021年间接受初级PCI治疗的348例STEMI患者,这些患者被纳入前瞻性MARINA-STEMI研究(NCT04113356)。在入院时和 STEMI 后 4 个月抽取外周静脉血样本进行血糖和糖化血红蛋白 (HbA1c) 测量。在两个时间点均进行了心脏磁共振(CMR)成像,包括用于评估梗死核心铁质的 T2* 映像。使用多变量回归分析计算了血糖异常与持续性梗死核心铁和4个月时铁溶解的关系:结果:基线时观察到心肌内出血的患者有 147 人(42%)。其中,89 人(61%)在梗死 4 个月后心肌梗死核心铁质持续存在,且随着 HbA1c 水平的升高而增加:在接受初级 PCI 治疗的 STEMI 患者中,以 HbA1c 定义的持续性血糖异常与持续性梗死核心铁质和较低的铁质溶解可能性独立相关。这些研究结果表明,持续性血糖异常与持续性梗死核心铁质之间存在潜在联系,值得进一步研究其治疗意义。
{"title":"Association of dysglycaemia with persistent infarct core iron in patients with acute ST-segment elevation myocardial infarction.","authors":"Ivan Lechner, Martin Reindl, Fritz Oberhollenzer, Christina Tiller, Magdalena Holzknecht, Priscilla Fink, Thomas Kremser, Paolo Bonatti, Felix Troger, Benjamin Henninger, Agnes Mayr, Axel Bauer, Bernhard Metzler, Sebastian J Reinstadler","doi":"10.1016/j.jocmr.2024.100996","DOIUrl":"10.1016/j.jocmr.2024.100996","url":null,"abstract":"<p><strong>Background: </strong>Dysglycaemia increases the risk of myocardial infarction and subsequent recurrent cardiovascular events. However, the role of dysglycaemia in ischemia/reperfusion injury with development of irreversible myocardial tissue alterations remains poorly understood. In this study we aimed to investigate the association of ongoing dysglycaemia with persistence of infarct core iron and their longitudinal changes over time in patients undergoing primary percutaneous coronary intervention (PCI) for acute ST-segment elevation myocardial infarction (STEMI).</p><p><strong>Methods: </strong>We analyzed 348 STEMI patients treated with primary PCI between 2016 and 2021 that were included in the prospective MARINA-STEMI study (NCT04113356). Peripheral venous blood samples for glucose and glycated hemoglobin (HbA1c) measurements were drawn on admission and 4 months after STEMI. Cardiac magnetic resonance (CMR) imaging including T2 * mapping for infarct core iron assessment was performed at both time points. Associations of dysglycaemia with persistent infarct core iron and iron resolution at 4 months were calculated using multivariable regression analysis.</p><p><strong>Results: </strong>Intramyocardial hemorrhage was observed in 147 (42%) patients at baseline. Of these, 89 (61%) had persistent infarct core iron 4 months after infarction with increasing rates across HbA1c levels (<5.7%: 33%, ≥5.7: 79%). Persistent infarct core iron was independently associated with ongoing dysglycaemia defined by HbA1c at 4 months (OR: 7.87 [95% CI: 2.60-23.78]; p < 0.001), after adjustment for patient characteristics and CMR parameters. The independent association was present even after exclusion of patients with diabetes (pre- and newly diagnosed, n = 16).</p><p><strong>Conclusions: </strong>In STEMI patients treated with primary PCI, ongoing dysglycaemia defined by HbA1c is independently associated with persistent infarct core iron and a lower likelihood of iron resolution. These findings suggest a potential association between ongoing dysglycaemia and persistent infarct core iron, which warrants further investigation for therapeutic implications.</p>","PeriodicalId":15221,"journal":{"name":"Journal of Cardiovascular Magnetic Resonance","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11211234/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139491343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiovascular magnetic resonance reference values of right ventricular volumetric variables in patients with hypoplastic left heart syndrome. 左心发育不全综合征患者右心室容积变量的 CMR 参考值。
IF 4.2 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-06-01 Epub Date: 2024-03-16 DOI: 10.1016/j.jocmr.2024.101038
Andrik Ballenberger, Amke Caliebe, Sylvia Krupickova, Anselm Uebing, Dominik Daniel Gabbert, Inga Voges

Background: Cardiovascular magnetic resonance (CMR) has established itself as the gold standard for serial assessment of systemic right ventricular (RV) performance but due to the lack of standardized RV reference values for hypoplastic left heart syndrome (HLHS) patients, the interpretation of RV volumetric data in HLHS remains difficult. Therefore, this study aimed to close this gap by providing CMR reference values for the systemic RV in HLHS patients.

Methods: CMR scans of 160 children, adolescents, and young adults (age range 2.2-25.2 years, 106 males) with HLHS were retrospectively evaluated. All patients were studied following total cavopulmonary connection. Short-axis stacks were used to measure RV end-diastolic and end-systolic volumes (RVEDV, RVESV), RV stroke volume (RVSV), RV ejection fraction (RVEF), and RV end-diastolic myocardial mass (RVEDMM). Univariable and multiple linear regression analyses were performed to assess associations between RV parameters and demographic and anthropometric characteristics. Following the results of the regression analysis, reference graphs and tables were created with the Lambda-Mu-Sigma method.

Results: Multiple linear regression analysis showed strong associations between body height and RVEDV, RVESV as well as RVSV. Age was highly associated with RVEDMM. Therefore, percentile curves and tables were created with respect to body height (RVEDV, RVESV, RVSV) and age (RVEDMM). The influence of demographic and anthropometric parameters on RVEF was mild, thus no percentile curves and tables for RVEF are provided.

Conclusion: We were able to define CMR reference values for RV volumetric variables for HLHS patients. These data might be useful for the assessment and interpretation of CMR scans in these patients and for research in this field.

背景:心血管磁共振(CMR)已成为连续评估系统性右心室(RV)性能的金标准,但由于缺乏针对 HLHS 患者的标准化 RV 参考值,对 HLHS 患者 RV 容量数据的解释仍很困难。因此,本研究旨在通过提供 HLHS 患者全身 RV 的 CMR 参考值来填补这一空白:回顾性评估了 160 名患有 HLHS 的儿童、青少年和年轻人(年龄在 2.2 岁至 25.2 岁之间,其中 106 名男性)的 CMR 扫描结果。所有患者都是在全腔肺连接后接受研究的。采用短轴堆叠法测量心室舒张末期和收缩末期容积(RVEDV、RVESV)、每搏量(RVSV)、射血分数(RVEF)和舒张末期心肌质量(RVEDMM)。为评估 RV 参数与人口学和人体测量特征之间的关联,进行了单变量和多元线性回归分析。根据回归分析的结果,采用 LMS 方法绘制了参考图和表格:结果:多元线性回归分析表明,身高与 RVEDV、RVESV 和 RVSV 之间存在密切联系。年龄与 RVEDMM 高度相关。因此,根据身高(RVEDV、RVESV、RVSV)和年龄(RVEDMM)绘制了百分位曲线和表格。人口统计学和人体测量参数对 RVEF 的影响较小,因此没有提供 RVEF 的百分位曲线和表格:结论:我们能够为 HLHS 患者的 RV 容积变量定义 CMR 参考值。这些数据可能对评估和解释这些患者的 CMR 扫描以及该领域的研究有用。
{"title":"Cardiovascular magnetic resonance reference values of right ventricular volumetric variables in patients with hypoplastic left heart syndrome.","authors":"Andrik Ballenberger, Amke Caliebe, Sylvia Krupickova, Anselm Uebing, Dominik Daniel Gabbert, Inga Voges","doi":"10.1016/j.jocmr.2024.101038","DOIUrl":"10.1016/j.jocmr.2024.101038","url":null,"abstract":"<p><strong>Background: </strong>Cardiovascular magnetic resonance (CMR) has established itself as the gold standard for serial assessment of systemic right ventricular (RV) performance but due to the lack of standardized RV reference values for hypoplastic left heart syndrome (HLHS) patients, the interpretation of RV volumetric data in HLHS remains difficult. Therefore, this study aimed to close this gap by providing CMR reference values for the systemic RV in HLHS patients.</p><p><strong>Methods: </strong>CMR scans of 160 children, adolescents, and young adults (age range 2.2-25.2 years, 106 males) with HLHS were retrospectively evaluated. All patients were studied following total cavopulmonary connection. Short-axis stacks were used to measure RV end-diastolic and end-systolic volumes (RVEDV, RVESV), RV stroke volume (RVSV), RV ejection fraction (RVEF), and RV end-diastolic myocardial mass (RVEDMM). Univariable and multiple linear regression analyses were performed to assess associations between RV parameters and demographic and anthropometric characteristics. Following the results of the regression analysis, reference graphs and tables were created with the Lambda-Mu-Sigma method.</p><p><strong>Results: </strong>Multiple linear regression analysis showed strong associations between body height and RVEDV, RVESV as well as RVSV. Age was highly associated with RVEDMM. Therefore, percentile curves and tables were created with respect to body height (RVEDV, RVESV, RVSV) and age (RVEDMM). The influence of demographic and anthropometric parameters on RVEF was mild, thus no percentile curves and tables for RVEF are provided.</p><p><strong>Conclusion: </strong>We were able to define CMR reference values for RV volumetric variables for HLHS patients. These data might be useful for the assessment and interpretation of CMR scans in these patients and for research in this field.</p>","PeriodicalId":15221,"journal":{"name":"Journal of Cardiovascular Magnetic Resonance","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11211216/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140158255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of 12-lead electrocardiogram at 0.55T for improved cardiac monitoring in magnetic resonance imaging. 评估 0.55T 磁共振成像中的 12 导联心电图,以改进磁共振成像心脏监测。
IF 6.4 1区 医学 Q1 Medicine Pub Date : 2024-06-01 Epub Date: 2024-02-10 DOI: 10.1016/j.jocmr.2024.101009
Aravindan Kolandaivelu, Christopher G Bruce, Felicia Seemann, Dursun Korel Yildirim, Adrienne E Campbell-Washburn, Robert J Lederman, Daniel A Herzka

Background: The 12-lead electrocardiogram (ECG) is a standard diagnostic tool for monitoring cardiac ischemia and heart rhythm during cardiac interventional procedures and stress testing. These procedures can benefit from magnetic resonance imaging (MRI) information; however, the MRI scanner magnetic field leads to ECG distortion that limits ECG interpretation. This study evaluated the potential for improved ECG interpretation in a "low field" 0.55T MRI scanner.

Methods: The 12-lead ECGs were recorded inside 0.55T, 1.5T, and 3T MRI scanners, as well as at scanner table "home" position in the fringe field and outside the scanner room (seven pigs). To assess interpretation of ischemic ECG changes in a 0.55T MRI scanner, ECGs were recorded before and after coronary artery occlusion (seven pigs). ECGs was also recorded for five healthy human volunteers in the 0.55T scanner. ECG error and variation were assessed over 2-minute recordings for ECG features relevant to clinical interpretation: the PR interval, QRS interval, J point, and ST segment.

Results: ECG error was lower at 0.55T compared to higher field scanners. Only at 0.55T table home position, did the error approach the guideline recommended 0.025 mV ceiling for ECG distortion (median 0.03 mV). At scanner isocenter, only in the 0.55T scanner did J point error fall within the 0.1 mV threshold for detecting myocardial ischemia (median 0.03 mV in pigs and 0.06 mV in healthy volunteers). Correlation of J point deviation inside versus outside the 0.55T scanner following coronary artery occlusion was excellent at scanner table home position (r2 = 0.97), and strong at scanner isocenter (r2 = 0.92).

Conclusion: ECG distortion is improved in 0.55T compared to 1.5T and 3T MRI scanners. At scanner home position, ECG distortion at 0.55T is low enough that clinical interpretation appears feasible without need for more cumbersome patient repositioning. At 0.55T scanner isocenter, ST segment changes during coronary artery occlusion appear detectable but distortion is enough to obscure subtle ST segment changes that could be clinically relevant. Reduced ECG distortion in 0.55T scanners may simplify the problem of suppressing residual distortion by ECG cable positioning, averaging, and filtering and could reduce current restrictions on ECG monitoring during interventional MRI procedures.

背景:12 导联心电图(ECG)是在心脏介入手术和压力测试期间监测心脏缺血和心律的标准诊断工具。然而,磁共振成像(MRI)扫描仪的磁场会导致心电图失真,从而限制心电图的解读。本研究评估了在 "低磁场 "0.55T MRI 扫描仪中改进心电图解读的潜力。方法:在 0.55T、1.5T 和 3T MRI 扫描仪内,以及在边缘磁场中扫描台 "原点 "位置和扫描室外(7 头猪)记录 12 导联心电图。为了评估在 0.55T 磁共振成像扫描仪中对缺血性心电图变化的解读,在冠状动脉闭塞前后记录了心电图(7 头猪)。此外,还在 0.55T 扫描仪上记录了 5 名健康人类志愿者的心电图。在 2 分钟的记录中评估了与临床解释相关的心电图误差和变化:PR 间期、QRS 间期、J 点和 ST 段:结果:与更高磁场的扫描仪相比,0.55T 的心电图误差更小。只有在 0.55T 工作台原点位置,误差才接近指南建议的 0.025mV 心电图失真上限(中位数为 0.03mV)。在扫描仪等中心位置,只有在 0.55T 扫描仪上,J 点误差才在 0.1mV 的阈值范围内,可用于检测心肌缺血(猪的中位数为 0.03mV,健康志愿者的中位数为 0.06mV)。冠状动脉闭塞后,J 点偏差在 0.55T 扫描仪内外的相关性在扫描仪工作台原点位置非常好(r2 = 0.97),在扫描仪等中心位置非常强(r2 = 0.92):结论:与 1.5T 和 3T 磁共振成像扫描仪相比,0.55T 磁共振成像扫描仪的心电图失真有所改善。在扫描仪原点位置,0.55T 的心电图失真很低,临床解释似乎是可行的,无需对病人进行更麻烦的重新定位。在 0.55T 扫描仪等中心位置,冠状动脉闭塞时的 ST 段变化似乎可以检测到,但失真足以掩盖可能与临床相关的细微 ST 段变化。在 0.55T 扫描仪中减少心电图失真可简化通过心电图电缆定位、平均化和过滤来抑制残余失真的问题,并可减少目前在介入 MRI 程序中对心电图监测的限制。
{"title":"Evaluation of 12-lead electrocardiogram at 0.55T for improved cardiac monitoring in magnetic resonance imaging.","authors":"Aravindan Kolandaivelu, Christopher G Bruce, Felicia Seemann, Dursun Korel Yildirim, Adrienne E Campbell-Washburn, Robert J Lederman, Daniel A Herzka","doi":"10.1016/j.jocmr.2024.101009","DOIUrl":"10.1016/j.jocmr.2024.101009","url":null,"abstract":"<p><strong>Background: </strong>The 12-lead electrocardiogram (ECG) is a standard diagnostic tool for monitoring cardiac ischemia and heart rhythm during cardiac interventional procedures and stress testing. These procedures can benefit from magnetic resonance imaging (MRI) information; however, the MRI scanner magnetic field leads to ECG distortion that limits ECG interpretation. This study evaluated the potential for improved ECG interpretation in a \"low field\" 0.55T MRI scanner.</p><p><strong>Methods: </strong>The 12-lead ECGs were recorded inside 0.55T, 1.5T, and 3T MRI scanners, as well as at scanner table \"home\" position in the fringe field and outside the scanner room (seven pigs). To assess interpretation of ischemic ECG changes in a 0.55T MRI scanner, ECGs were recorded before and after coronary artery occlusion (seven pigs). ECGs was also recorded for five healthy human volunteers in the 0.55T scanner. ECG error and variation were assessed over 2-minute recordings for ECG features relevant to clinical interpretation: the PR interval, QRS interval, J point, and ST segment.</p><p><strong>Results: </strong>ECG error was lower at 0.55T compared to higher field scanners. Only at 0.55T table home position, did the error approach the guideline recommended 0.025 mV ceiling for ECG distortion (median 0.03 mV). At scanner isocenter, only in the 0.55T scanner did J point error fall within the 0.1 mV threshold for detecting myocardial ischemia (median 0.03 mV in pigs and 0.06 mV in healthy volunteers). Correlation of J point deviation inside versus outside the 0.55T scanner following coronary artery occlusion was excellent at scanner table home position (r<sup>2</sup> = 0.97), and strong at scanner isocenter (r<sup>2</sup> = 0.92).</p><p><strong>Conclusion: </strong>ECG distortion is improved in 0.55T compared to 1.5T and 3T MRI scanners. At scanner home position, ECG distortion at 0.55T is low enough that clinical interpretation appears feasible without need for more cumbersome patient repositioning. At 0.55T scanner isocenter, ST segment changes during coronary artery occlusion appear detectable but distortion is enough to obscure subtle ST segment changes that could be clinically relevant. Reduced ECG distortion in 0.55T scanners may simplify the problem of suppressing residual distortion by ECG cable positioning, averaging, and filtering and could reduce current restrictions on ECG monitoring during interventional MRI procedures.</p>","PeriodicalId":15221,"journal":{"name":"Journal of Cardiovascular Magnetic Resonance","volume":null,"pages":null},"PeriodicalIF":6.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10940178/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139717545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Cardiovascular Magnetic Resonance
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1